IMCR
Immunocore AmericanFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Composite grade F from latest DB weights. Momentum 25.3 / Value 48.3
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
25
Value
48
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $65.05
Why
Momentum25 · Δ7d +2.4
Value48 · Δ7d +0.0
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
25
52% active weight
Current posture
7d trendSoftening
Δ7d
+2.4
Δ21d
+12.8
Value
48
48% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.1
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 25.3 / Value 48.3
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$1.48B
Beta
0.78
Shares Out
50.53M
P/E (TTM) · Derived
-41.4
P/S (TTM)
4.36
P/FCF (TTM)
561.35
Rev YoY
+29.2%
EPS YoY
-102.1%
Gross Margin
+99.3%
Op Margin
-11.9%
Net Debt
-$429.36M
Current Ratio
6.00
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology